HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Is it useful to modify the care of Klinefelter's syndrome to improve the chances of paternity?].

Abstract
Until a few years ago, Klinefelter syndrome with a homogeneous 47.XXY karyotype was considered a model of absolute male sterility. In this review, we will discuss: (1) potential fertility following TEsticular Sperm Extraction-IntraCytoplasmic Sperm Injection (TESE-ICSI), (2) the physiopathology of spermatogenic failure and the origin of focal spermatogenesis and risk of aneuploidy in potential offspring, (3) the advantage of searching for and cryopreserving spermatozoa in adolescent instead of adult patients. In previous published series, TESE was successful in almost 50% of patients and pregnancy rate following ICSI was not obviously different from other causes of spermatogenic failure. The rate of positive sperm extraction seemed to be better for younger patients. During childhood, the survival rate of 47.XXY spermatogonia is low. However, a few spermatogonia are able to eliminate their extra X chromosome, giving rise to rare clones of 46.XY gonia which are the origin of rare foci of complete spermatogenesis after puberty. Several arguments suggest that this focal spermatogenesis decreases with age. This suggests there would be a benefit to patients if TESE were performed in adolescences and spermatozoa were cryopreserved. In addition, androgenotherapy is a common treatment of Klinfelter syndrome but carries a risk of decreasing focal spermatogenesis by lowering gonadotropins. Preservation of spermatozoa from adolescence by TESE would allow androgenotherapy to be prescribed with less concern for future reproductive capacity. Controlled studies should be done to determine the best age for TESE-ICSI in 47.XXY homogeneous Klinefelter syndrome patients.
AuthorsI Plotton, A Brosse, H Lejeune
JournalAnnales d'endocrinologie (Ann Endocrinol (Paris)) Vol. 71 Issue 6 Pg. 494-504 (Dec 2010) ISSN: 2213-3941 [Electronic] France
Vernacular TitleFaut-il modifier la prise en charge du syndrome de Klinefelter pour améliorer les chances de paternité ?
PMID20727517 (Publication Type: English Abstract, Journal Article, Review)
CopyrightCopyright © 2010. Published by Elsevier Masson SAS.
Topics
  • Adolescent
  • Adult
  • Female
  • Humans
  • Infertility, Male (etiology, therapy)
  • Klinefelter Syndrome (complications, therapy)
  • Male
  • Paternity
  • Pregnancy
  • Reproductive Techniques, Assisted
  • Sperm Injections, Intracytoplasmic
  • Spermatogenesis (physiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: